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ABSTRACT 
EFFECTS OF DIET ARY CORN OIL AND MENHADEN OIL ON RAT 
MAMMARY TUMORIGENESIS AND PROSTAGLANDIN E2 LEVELS 
Melissa L. Philley 
Morehead State University, 1 988 
Director of Thesis: 
Promotion of mammary tumors by dietary lipids has been 
established by experimental and epidemiological research. 
Menhaden oil, a fish oil, however, has been shown to have an 
inhibitory effect upon mammary tumorigenesis in rodent models. 
This inhibition may be attributed to the biochemical effects of the 
omega-3 fatty acids in menhaden oil as opposed to the omega-6 
fatty acids of corn oil, a known promoter of mammary tumors. 
This study was undertaken to evaluate the effects of 
different levels of dietary menhaden oil (MO) and corn oil (CO) on 
tumorigenesis and prostaglandin (PG) levels. At 50 days of age, 
120 female Sprague-Dawley rats were given 10 mg of 7,12-
dimethylbenz(a)anthracene by gastric intubation. Twenty rats 
were assigned to one of six isocaloric diets: 1) 3.9% CO, 2) 3.9% 
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MO, 3) 19.4% CO, 4) 19.4% MO, 5) 15.5 % C0:3.9 % . MO, and 6) 15.5 % 
M0:3.9% CO. The animals were sacrificed on day 127. 
Results showed that the 3.9% MO diet was not inhibitory to 
tumorigenesis. However, rats fed diets containing 19.4% MO 
exhibited lower tumor burden, less rapid tumor growth and lower 
tumor PGE2 levels. When rats fed high menhaden oil 05.5%) were 
supplemented with 3.9% corn oil, tumor inhibition was abolished 
even though the total lipid levels were the same. Body weights 
and tumor data of rats on this diet (15.5% M0:3.9% CO) were non-
significantly elevated when compared to all other groups. The 
only rats significantly inhibited in all evaluations were those fed 
high menhaden oil. 
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INTRODUCTION 
In the United States one of ten women develop breast 
cancer, the most frequent cause of death among women ( 1 ). 
There is also evidence of the importance of the early- onset of 
puberty in increasing the risk of breast cancer. Other risks 
include the family history of the disease, nulliparity, as well as 
first child after age thirty (2). However, dietary influences have 
long been suspecte_d as an important cause of breast cancer (3). 
Epidemiological and laboratory studies suggest a positive 
correlation between dietary fat intake and cancer of the breast, 
colon, and prostate ( 4 ). 
Diet and Cancer 
In experimental animals, both the amount and type of fat 
in the diet have been shown to influence development of 
carcinoma of breast, colon, and prostate (5). Some evidence 
suggests that saturated fat may influence the initiation stage of 
mammary tumorigenesis and that polyunsaturated fatty acids act 
on the promotional phase ( 2,6 ). Initiation, an early and 
irreversible stage in the carcinogenic process, is produced by a 
single or very limited application of_ a carcinogen. Promotion is 
the stimulation of development frcim an initiated cell to a tumor. 
1 
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Some dietary modifications have been shown to be capable 
of altering eacp. stage of tumor development (2). Many studies 
with rats and mice have shown that unsaturated fats, mainly 
those in the linoleic family, are the most effective in the 
enhancement of the promotional phase of mammary 
tumorigenesis (6,7). In 1985, Ip et al. observed that mammary 
tumor development appeared to increase in a step-wise fashion 
with increasing fatty acid levels in the diet up to 4.4%. Increases 
in fatty acids above this level appear to have minimal effects (7). 
A number of mechanisms have been proposed to explain the 
enhancement of mammary neoplasia. These include: 
( 1) suppression of immune responses, 
(2) inhibition of intercellular communication, 
(3) increase in secretion of mammotropic hormones, 
( 4) alteration of membrane structure and properties, and 
(5) increase in production of cyclooxygenase products of 
arachidonic acid (8). 
Vegetable oils, such as corn oil, contains high levels of 
lenoleic acid (18:2n-6), the precursor of arachidonic acid (20:4n-6) 
and ultimately dienoic eicosanoids or prostaglandins of the 2-
series (9 ). These dienoic eicosanoids have been implicated by 
several investigators as the stimulator of the promotional phase of 
mammary tumorigenesis (10). 
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7, 12- dimethylbenz(alanthracene (DMBA) 
DMBA (Figure 1) is a synthetic polycyclic aromatic 
hydrocarbon (PAH) commonly used in the initiation of the rat 
mammary tumors. 
Figure 1. The structure of DMBA. Taken from Huggins (11). 
DMBA works consistently and rapidly in a single 10-
milligram dose ( 12 ). Huggins reported that after a single 20-
milligram dose of 7.12-DMBA, the maximum number of mammary 
tumors ob served in a rat was 21 ( 13 ). Certain conditions under 
which mammary cancers are initiated by DMBA include the 
nature of the hydrocarbon, dosage, species of the rat, strain, age, 
and hormonal status of the rat ( 13 ). Huggins discovered that 
mammary tumors induced by DMBA in female Sprague-Dawley 
rats are similar to human breast tumors in that they are easily 
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palpable and hor mane responsive. Also, since they do not 
metastasize to new tumor sites, the DMBA-induced model is useful 
in experimentation. ( 13). The effectiveness of· DMBA as an 
initiator of tu morigenesis is illustrated in Table I. Mammary 
tumors, primarily adenocarcinomas consist of mammary acini 
lined with many layers of epithelial cells arranged to form gland-
like structures with papillary projections. This type of tumor can 
occur from neck to perineum and usually cause death through 
hemorrhage, necrosis, and ulceration due to enormous size rather 
than metatasis ( 11 ). 
Table I. Incidence of neoplasms in rats fed DMBA. Taken from 
Huggins ( 11 ). 
TUMORS PERCENT 
Mammary cancer 100 
Fibroadenoma 89 
Leukemia 3 
Ear duct cancer s 
Carcinogens can be divided into two classes based on the 
electrophilic hypothesis of carcinogenesis, which states that most, 
if not all, chemical carcinogens are metabolized to biologically 
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reactive electrophils that exert their carcinogenic activity (2 ). 
DMBA is taken up by the liver, metabolized, and excreted into the 
bile or exported. Mammary tissue can metabolize DMBA to a 
slight extent. DMBA is primarily metabolized by the oxidation of 
the methyl groups and, less completely, by the ring structure ( 11 ). 
The main electrophilic intermediates, the bay-region of 
syn- and anti-3,4-dihydrodiol-1,2 epoxides, are thought to bind 
to DNA to exert carcinogenic activity (15). These epoxides bind 
covalently to deoxyadenosine and deoxyguanosine residues of 
DNA (15). 
In 1971, researchers discovered that DMBA bound 
preferentially to the number one chromosone in rats and was 
expressed in the late interphase and prophase of the cell cycle 
( 11 ). Within 24 hours of injection with DMBA, one half of the cells 
in metaphase in bone marrow had chromosomes with breaks and 
gaps ( 11). 
Essential Fatty Acids 
Dietary polyunsaturated fatty acids are the only source of 
essential fatty acids (EFA) required by man and other mammals. 
EFA covers a wide range of 18-, 20-, and 22-carbon chain length 
polyunsaturated fatty acids (PUFA) with 2 to 6 methylene 
interrupted double bonds with the cis configuration. Neither of 
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the two classes, the linoleic (omega-6) and linolenic ( omega-3 ), 
can be synthesized by mammalian organisms (16). There are two 
main EFAs that are manufactured by plants and not by mammals-
the cis:cis-linoleic acid (18 :2 n-6) and the cis:cis:cis-alpha-Iinolenic 
acids (18:3 n-3). These are metabolized in the body as shown in 
Figure 2. EFAs of the n-6 and n-3 type appear to compete for the 
same enzyme systems, with the n-3 compounds being 
preferentially metabolized ( 17). In order for a fatty acid to have 
EFA activity, all its double bonds must be in the cis configuration. 
Even one bond in the trans form leads to loss of EFA activity and 
to competitive inhibition of the metabolism of all cis EFAs. Many 
commercially available oils contain substantial amounts of trans 
acids and the factor should be taken into account ( 17). 
The parent EFA can undergo chain elongation and 
desaturation to produce long-chain derivatives of 20- and 22-
carbons with 3 to 6 double bonds ( 16). As seen in Figure 2, 
linoleic acid is desaturated to form gamma-linoleic acid which is, 
in turn, elongated to give rise to dihomogammalinoleic acid, the 
precursor of the series one prostaglandins (PGE 1 and PGE 1 alpha). 
Dihomogammalinoleic acid can be desaturated also to arachidonic 
acid, the precursor of the series two prostaglandins (PGE2 and 
PGE2 alpha), thromboxanes and leukotrienes. Of the omega-3 
fatty acids, alpha linolenic acid is desaturated_ and elongated to 
create eicosapentaenoic acid (EPA), the precursor of the series 
n-6 EFAs n-3 EFAs 
Linoleic 18:2n-6 l8:3n-3 Alpha-linolenic 
1 delta-6-desaturase l 
Gamrna-linolenic 18:3n-6 l8:4n-3 
Dihomogamrnalinolenic (DGLA) 20:3n-6 20:4n-3 
l delta-5-desaturase l 
Arachidonic (AA) 20:4n-6 20:Sn-3 Eicosapentaenoic (EPA) 
Adrenic 22:4n-6 22:Sn-3 
1 delta-4-desaturase l 
22:Sn-6 22:6n-3 Oocosahexaenoic (DHE) 
Figure 2. Metabolism of two main dietary EFAs, linoleic acid 





three prostaglandins (PGE3 and PGE3 alpha). EPA is further 
converted to docosahexaenoic acid (DHA). The resulting fatty 
acids are fuctional components of cell membranes. They 
determine membrane fluidity and flexiblity and modulate 
permeability and the functioning of membrane-bound enzymes 
and receptors (17). 
Because of their polyunsaturation, the EFAs are susceptible 
to oxygen attack with the formation of peroxidized fatty acids 
which are highly toxic and may be involved in the metabolic 
activation of carcinogens. Peroxides may be formed from EFAs 
prior to consumption or within the body itself. Animals have 
developed complex mechanisms for protecting themselves against 
peroxides, both by reducing formation and increasing removal of 
them ( 17). 
Essential fatty acids are essential nutrients that play a 
major role in the normal development of the mammary glands 
and are also constituents of all cell membranes ( 18 ). Therefore, it 
is possible that malignant tumors derived from mammary glands 
require EFAs for growth and as with any essential nutrient, it will 
be possible to demonstrate that deprivation of EFAs will inhibit 
tumor growth and that provision of the nutrients will stimulate 
growth ( 17). Animal studies done by Ip et al. sugggest that 1 to 
2% of the total calories in the form of linoleic acid is the minimum 
required to prevent EFA deficiency and that mammary 
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development in rodents may fail at EFA levels which do not 
maintain normal growth. This _suggests that more linoleic acid, 
about a minimum of approximately 4% of total calorie intake, may 
be required for the mammary gland (7). 
The main conclusions from Cohen's series of studies 
involving animal mammary tumors and essential fatty acids are: 
1) Animals on a high-fat diet develop more tumors earlier 
than animal on a low-fat diet. 
2) Animals on a EFA-deficient diet have a reduced risk of 
tumor formation. 
3) The fat effect is not related to any action on the 
absorption of lipid-soluble carcinogen (DMBA) or on its uptake 
into mammary tissue. 
4) A certain minimum level of EFA intake is required for 
maximum tumor development. About 2 to 3% of total caloric 
intake as EFAs seems to be the critical figure. Provided that this 
is present in the diet, high intakes of any type of fat, saturated, 
monounsaturated, and polyunsaturated are effective in further 
increasing tumor growth. Either n-6 or n-3 EFAs seem to be able 
to fulfill the minimum requirement. Since n-3 EFAs inhibit 
prostaglandin formation from arachidonic acid, this argues 
against prostaglandin formation being critical. 
5) Administering a high-fat intake.prior to the carcinogen 
with a normal or low-fat intake afterwards seems to have no 
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effect on tumor growth. In contrast, many weeks after giving 
DMBA, adding fat or withdrawing it from the diet is able to 
modulate tumor growth. 
6) And as an exception to the rule that fatty acids promote 
tumorigenesis, rapeseed oil, which contains erucic acid, can inhibit 
the conversion of linoleic acid to arachidonic acid and it inhibits 
the lipoxygenase enzyme which converts PUFAs to hydroxy-acids 
and Jeukotrienes ( 17). 
Menhaden oil 
Fish oils contain high concentrations of omega-3 fatty 
acids. Current interest in omega-3 fatty acids has been spawned 
from the observations that despite their high-fat, high cholesterol, 
low carbohydrate diet, Greenland Eskimos rarely die of 
cardiovascular disease and Alaskians have a I 0.3% death rate due 
to cardiovascular disease whereas approximately 50% of all deaths 
in the mainland United States are due to cardiovascular disease. 
These omega-3 fatty acids of interest are eicosapentaenoic (EPA) 
and docosahexaenoic (DHA) acids. They are found almost 
exclusively in seafood ( 19). Whereas corn oil, with its main 
constit'uent of linoleic acid, has been shown to greatly enhance 
tumorigenesis (2-7,14,17,18), several recent studies have 
demonstrated the inhibition of menhaden or fish oil on DMBA-
1 1 
induced mammary cancer (8,9, 16,20) and in transplanted 
mammary tumors (21-23). Table 2 taken from Abou-El-Ela et al. 
illustrates the fatty acid components of both corn oil and 
menhaden oil (9). 
Table 2. Fatty Acid Composition of Oils (%) (9). 
Fatty acid Corn oil Menhaden oil 
14:0 8.35 
16:0 11.2 15.17 




18:0 2.1 2.67 
18: 1 25.0 9.50 









others 0.1 4.37 
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In 1984, Kar mali et al .. used a MaxEPA marine oil to test 
the effect of omega-3 fatty acids on transplanted mammary 
tumors (20). They concluded that EPA and DHA replace the 
omega-6 fatty acids in the tissue lipid, plasma, and platelets 
membranes of their experimential animals, and that EPA and DHA 
should limit the synthesis of the 2-series of prostaglandins. These 
results suggested that the mechanism underlying tumor growth 
may be linked to arachidonic acid metabolism and may be similar 
to the effect of EPA and DHA in lowering platelet responsiveness 
in the Eskimos. They surmised that omega-3 fatty acids may 
exert their effects by competing with arachidonic acid for the 
cyclooxygenase enzyme, thereby reducing the synthesis of 
prostaglandin E2 from arachidonic acid (20). 
A study by Jurkowski and Cave in 1986 showed that while 
a 20% dietary fat level was effective in reducing tumor 
development, this was less apparent in 0.5% and 3% ·dietary fat 
level (22). Also, the animals given a diet of 0.5% menhaden oil 
developed more tumors than the 0.5% corn oil control group. 
The following year, Gabor and Abraham experimented 
with mixed diets of menhaden and corn oil (21). They observed 
that a diet of 10% menhaden oil and a mixed diet of 9% mehaden 
and 1 % corn oil were effective in inhibiting tumorigenesis, while a 
mixed diet of 7.5% menhaden oil and 2.5 % corn oil was not 
effective in significantly inhibiting tumorigenesis. 
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Menhaden oil has also been shown to inhibit NMU-induced 
mammary tumors (22), L-azaserine-induced preneoplastic lesions 
in rat pancreas (24), IX transplantable mammary 
adenocarcinomas (23), azomethane-induced colon tumors (25), 
and lung tumors (26). Current evidence suggests that further 
efforts are needed to establish the optimal dietary ratios of 
omega-3 and omega-6 fatty acids and the actual mechanism of 
action. 
Prostaglandin E2 
Prostaglandin is a term applied to a series of compounds 
derived enzymatically and nonenzymatically from twenty carbon 
fatty acids such as arachidonic acid and eicosahexaenoic acid. 
Research over the past twenty years has identified prostaglandins 
as products of almost every cell, although the amount and class of 
prostaglandin produced varies with cell type (27). The dienpic 
eicosanoids are formed from arachidonic acid which can be 
obtained only from dietary sources of omega-6 EFA (Figure 3). In 
normal mammary fat pads, levels of PGE2 (Figure 4) we·re not 
changed by increasing linoleate content of diet (9 ). The 
production and secretion of arachidonic products, particularly 
PGE2, is increased several fold in a large number of animal (9) 
and human (28, 29) tumors. 
14 






Y- linolenic octadecatetraenoic 
elongase 
j l 
C2O:3 series PGs C2O:4 
dihomo- Y-linolenic 2 series l Ts eicosatetraenoic 
ll 5 desaturase 
l l 
C2O:4 2 series PGs C2O:5 
arachidonic 4 series LTs eicosapentaenoic 
elongase OH fatty acids 
l l 
C22:4 C22:5 
docosatetraenoic 3 series PGs docosapentaenoic 
j 
5 series LTs 
l 
OH fatty acids 
C22:5 C22:6 
docosapentaenoic docosahexaenoic 
Figure 3. Formation of Eicosanoids. Taken from Karmali (8). 
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Further support for the prostaglandin-high-fat-diet-
mammary tumorigenesis hypothesis comes from reports 
suggesting that prostaglandin inhibitors such as indomethacin are 
effective in suppressing mammary tumorgenesis in rats fed diets 
high in unsaturated fatty acids. Indomethacin works by inhibiting 
the cyclooxygenase component of the prostaglandin synthetase 
enzyme system (10). 
Along with the inhibitory effect on mammary tumor 
growth, diets rich with fish oil may also be able to control tumor 
cell metastasis. EPA and DHA have the ability to alter platelet 
function though the reduction of thromboxane A2 synthesis and 
by these means can possibly interfere with tumor cell platelet 
interaction, an important mechanism in tumor cell metastasis (31 ). 
However, when analyzing prostaglandins it is essential to 
process tumors as soon as possible due to· the !ability of the 
enzymes associated with prostaglandin synthesis. Substantial 
amounts of prostaglandins may be generated in response to 
trauma and variation in degree of tissue trauma might be 
















Figure 4. Structure of prostaglandin E2. Taken from Martin (30). 
Research Objectives 
In this study, the effects of dietary menhaden oil, rich in 
omega-3 fatty acids, were studied on tumor incidence, tumor 
number, tumor burden per tumor bearing rat, and tumor PGE2 
levels. High- and low-fat diets as well as mixed diets of 
menhaden and corn oil were compared. It was hypothesized that 
rats fed a high-fat diet of menhaden oil would show a decreased 
tumor incidence, tumor number, tumor burden, and PGE2 levels 
when compared to high-fat corn oil. The effect of mixed diets on 
tumorigenesis is controversial and preliminary effects are 
unknown (9,22-24). 
MATERIALS AND METHODS 
Animal Treatment 
One hundred and twenty female Sprague-Dawley rats, 36 
to 40 days of age, were obtained from Harlen Sprague-Dawley 
Inc., Indianapolis, Indiana. The rats were housed in stainless steel 
cages, one per cage, in a temperature- and light-controlled room 
( 141: 1 OD). Food and water were given ad libitum. At 50 days of 
age, each animal was lightly etherized and given a 10-milligram 
dose of DMBA in 1 ml of corn oil by intragastric intubation. 
Twenty rats were then assigned to one of six groups: 1) 3.9% corn 
oil (3.9%C0), 2) 3.9% menhaden oil (3.9%MO), 3) 19.4% corn oil 
( 19.4%CO), 4) 19.4% menhaden oil ( 19.4%MO), 5) 15.5% corn oil & 
3.9% menhaden oil (15.5%C0:3.9%MO), and (6) 15.5 % menhaden 
oil & 3.9% corn oil ( 15.5%MO:3.9%CO). These percentages reflect 
low and high concentrations of lipids. The components of all diets 
were expressed in percentage by weight and all diets were 
isocaloric (Table 3). All diets were prepared to contain 3.51 
kilocalories per gram. The casein, cellulose, minerals, vitamins, 
methionine, choline, and menhaden oil were purchased from 
United States Biochemical Corporation, Cleveland, Ohio. The 
sucrose and corn oil were purchased locally. One rat in the 3.9% 
corn-oil group died in the ninth week due to unrelated causes. 
17 
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Five weeks following initiation, all rats were palpated 
weekly for tumor growth. At day 77, all rats were sacrificed by 
decapitation and their total number of tumors measured in three 
dimensions with calipers. Tumor position and dimensions were 
recorded on a rat diagram. 
Each tumor from each tumor-bearing rat was dissected, 
placed in polypropylene tubes containing 0.5 milliliters of 
indomethacin at a concentration of 10 micrograms per milliliter 
(31 ). The tumors were then frozen in a mixture of dry ice and 
acetone and stored at -20 degrees Celsius. 
Table 3. Diet concentrations by percentage. 
COMPONENT HIGH FAT DIET LOW FAT DIET 
Casein 21.6% 21.7% 
Sucrose 21.9 % 57.0% 
Oil 19.4% 3.9% 
Cellulose 31.8% 12.1 % 
Minerals 3.8% 3.8% 
Vitamins 1.0% 1.0% 
Methionine 0.3% 0.3% 
Choline 0.2% 0.2% 
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PGE2 Extraction and Determination 
PGE2 extraction was performed according to the procedure 
of Abou-El-Ela et al. (9). Tumors were finely minced at 4 to 6 
degrees Celsius and placed in Krebs Ringer Bicarbonate Glucose 
solution in a concentration of 1 gram per 5 milliliters. They were 
then incubated of 37 degrees Celsius for one hour in 95% 
oxygen/5% carbon dioxide environment. The tumor samples were 
homogenized for 15 seconds at 8 amperes with a Branson sonifier 
(Branson Instruments Inc., Stanford, CT) and acidified to a pH 3 
with 0.8M phosphoric acid. The prostaglandins were extracted 
with four volumes of ethyl acetate with .vigorous shaking. The 
organic phase was removed and 50 microliters of 0.!M Tris HC! 
buffer (pH 7.5) was added. The organic phase was then 
evaporated under nitrogen and the residue was reconstituted with 
an appropriate aliquot of assay buffer (9). PGE2 concentrations 
were determined using a prostaglandin E2 [125 I] RIA kit (Dupont 
Biomedical Products, Boston, Massachusetts). Antiserum and 
radioactive tracer were added to each sample and these were 
incubated for 16 to 24 hours at 2 to 8 degrees Celsius. Following 
the appropriate time, the precipitating reagent was added and the 
samples were centrifuged at I 000 to 20 00 x g at 4 to 6 degrees 
Celsius. The excess fluid from each tube was removed and the 




Analysis of variance and Duncan's multiple range test were 
used to determine the significance of the results at p< .05. 
RESULTS AND DISCUSSION 
Each group, except 19.4% menhaden oil, developed tumors 
by the end of the fifth week (Table 4). Only one tumor in the 
19.4% menhaden oil group was found and not until the time of 
autopsy. High concentrations of menhaden oil ( 19.4%) also greatly 
reduced the percentage of rats with tumors in comparison to the 
other groups. However, more than half of the rats receiving 3.9% 
menhaden oil developed tumors. This suggests that low levels of 
fish oil do not inhibit tumorigenesis. Since 60% of the rats 
receiving diets of 15.5% menhaden oil and 3.9% corn oil were 
tumor positive, high levels of the menhaden oil mixed with low 
levels of corn oil also were not inhibitory. This suggests that 
minimal levels of corn oil mixed with high levels of menhaden oil 
eliminated the tumor inhibition by the fish oil alone even though 
the percentage of lipids was the same in both diets. 
A comparison of body weights at death can be seen in 
Table 5. Rats in the 19.4% menhaden oil had body weights that 
were significantly lower than all groups. Also, rats on diets of 
3. 9 % CO, 3. 9 % MO, and 1 9 .4 % CO had body weights that were 
significantly reduced compared to the 15.5%MO:3.9%CO group. 
This addition of 3.9% corn oil to the diets significantly elevated the 
body weights compared to the rats receiving 19.4% menhaden oil 




weight gain is associated with decreased tumor development, it is 
erroneous to think that the associated weight development is the 
single cause for decreased tumorigenesis when the diet causes a 
rich diversity of other physiological and biochemical effects (24). 
Table 4. Comparison between groups, percentage of rats with 
tumors and first day of tumor occurrence in relation to palpation 
schedule. 
GROUP PERCENTAGE FIRST DAY OF OCCURRENCE 
3.9%CO 42% 41 
3.9%MO 55% 41 
19.4%CO 35% 41 
19.4%MO 5% 77 
15.5%CO:3.9%MO 45% 41 
15.5%MO:3.9%CO 60% 41 
Analysis of data between all groups was somewhat 
difficult due to the fact that only one tumor was found in the 
19.4% menhaden oil group (Table 6). While 19.4% menhaden oil 
group had only one tumor, the 3.9% MO and 15.5%MO:3.9%CO 
groups had high numbers of tumors. It is unknown why the 
19.4% CO had the same number of tumors (13) as the 3.9% CO, in 
light of published reports that high corn oil diets generally yield 
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greater tumor numbers than low corn oil diets. The low-fat corn 
oil group, at 2.3% linoleic acid, is below the linoleic acid level (4%) 
required for mammary tu morigenesis and the high-fat corn oil 
diet, at 11.6 % linoleic acid, is much above this level (7). Therefore, 
the higher fat diet should have produced a significantly higher 
number of tumors. 






























Fcal 5.14 > Ftab 2.29 
MEAN STD. DEV. 
22 9 ( a) 23.5 
231 (a) 23.5 
224 (a) 16.5 
195 (b) 17.8 
233 16.2 
245 17.5 
a significantly different from 15.5%MO:3.9%CO at p<.05. 
b significantly different from all groups at p<.o5. · 
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Table 6. Comparison between groups of total tumors, average 
tumor number per rat, and tumor number per tumor bearing rat. 
Group Total Average tumor # Tumor # per 
tumor tumors per group bearing rat 
3.9%CO 13 .68(a) 1.6 
3.9%MO 23 1.15 2.1 
19.4%CO 13 .75(a) 1.9 
19.4%MO 1 .05(a,b) 1.0 
15.5%CO:3.9%MO 18 .90 2.0 
15.5 %MO:3. 9 %CO 32 1.60 2.7 
a significant at p<.05 from 15.5 %MO:3.9%CO. 
b significant at p<.05 from 3.9%MO and 15.5%CO:3.9%MO. 
Average tumor number per group was significantly lower 
in the 19.4% MO group. Tumor number per tumor-bearing rat 
was also much lower in the 19.4% menhaden oil group and highest 
in the 3.9% MO and 15.5%MO:3.9%CO groups. These effects in the 
3.9% MO group has been observed by several researchers and 
implies that additional biochemical features of the lipids must be 
involved (22,32). The effects of mixed dietary ratios of corn oil 
and menhaden oil are inconclusive. This research suggests that 
the 3. 9 % menhaden oil added to the 15.5 % corn oil does not 
suppress tumorigenesis, but that the 3.9% corn oil added to the 
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15.5% menhaden oil overcomes the inhibition of 19.4% menhaden 
oil alone. 
Figures 5 and 6 illustrate total tumor burden per tumor-
bearing rat per group and average tumor volume per tumor-
bearing rat, respectively. Although there was no significant 
difference among the five statistically analyzed groups, in both 
figures the obvious difference is the low tumor volumes of the 
19.4% menhaden oil group. The average tumor volume per group 
in Figure 7 again illustrates this difference. The general trend 
from Figures 5, 6, and 7 is that rats fed diets of either low 
menhaden oil alone or high menhaden oil plus low corn oil have 
non-significantly elevated tumor data. 
Although there was no significant difference among the 
comparable groups, there was a noticeable difference in level of 
. ' 
PGE2 in the 19.4% menhaden-oil group (Table 7). This lower 
picogram amount correlates with the findings of the majority of 
researchers that a high-fat dietary level of menhaden oil is 
effective in depressing tumorigenic activity in induced mammary 
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Figure 6. Ayerage Tumor Volume per Tumor Bearing Rat per Group 
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Table 7. Picograms of prostaglandin E2 per dietary group. 
GROUP PICOGRAMS STD.DEV. 
3.9%CO 6.6 4.2 
3.9%MO 6.1 2.2 
l 9.4%CO 5.1 2.5 
l 9.4%MO 3.8 
15.5%CO:3.9%MO 6.7 3.8 
15.5%MO:3.9%CO 6.1 2.0 
In summary, although the mixed diets proved inconclusive 
and that a 3.9% diet of menhaden oil enhanced tumorigenesis, the 
obvious conclusion is that a high-fat diet of only menhaden oil 
was distinctly effective in inhibiting tumorigenesis. The exact 
mechanism by which this happens is as of yet elusive; however, 
these data are supportive of the hypothesis that the omega-3 
fatty acids (EPA and DHA) contained in menhaden oil are 
inhibitory to the enzymes of prostaglandin E2 synthesis. 
However, it is possible that the inhibition by 19.4 % menhaden oil 
is a result of the lowering of body fat and lack of essential fatty 
acids of the n-6 series. A comparison of body weights, tumor 
incidence, and tumor weights showed significant reduction in rats 
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menhaden oil compared to the 15.5% menhaden oil/ 3.9% corn oil 
group. These reductions may be due to low energy reserves in 
the 19.4% rats, a hypothesis that has been reported by 
Kritchevsky et al. (34). 
However, caution must be exerted when evaluating these 
benefits for human use. Much more experimentation needs to be 
done to evaluate the ratios at which omega-3 fatty acids are 
effective. As shown in this study, a low-fat diet of· menhaden oil 
and a mixed diet high in menhaden oil were actually stimulato·ry 
in their effectiveness in tumorigenesis. 
Fish oil capsules now available contain 3 0 0 to 5 0 0 
milligrams of omega-3 fatty acids per capsule. Therefore, 15 to 
30 capsules must be taken per day to equal the amount used in 
many experimental studies. At this dosage, it would add 570 to 
1130 kJ per day to the diet. If the diet were not adjusted to 
accommodate the increase, then a gain of 11 kg of fat tissue would 
occur annually. Other adverse side effects would include vitamin 
A and D toxicity and vitamin E difficiency. 
Superfically, omega-3 fatty acids appear to be a great hope 
'for the prevention of dietary fat related cancers. At this moment 
the actual benefits versus adverse side effects make any human 
use of fish oil a possible hazard. and research is conflicting. 
However, with more research and other possible treatments, 
31 
many cancer tragedies through simple dietary modifications may 
be prevented. 
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